Weekly weight-loss injection combo shows promise
Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health condition such as high blood pressure or sleep apnea, according to the REDEFINE 9 randomized controlled trial published in The Lancet Diabetes & Endocrinology journal.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.